Embracer appoints Phil Rogers as new CEO

Published on 10/06/2025 at 14:32

Finwire - Translated by Marketscreener - See original

-1.38%

Latest news about Embracer Group AB

Aktiespararna is making three changes to its portfolios	06-13	FW
Embracer Group AB Announces CEO Changes, Effective August 1, 2025	06-10	CI
Embracer Group Proposes New CEO, Executive Chair	06-10	MT
Embracer appoints Phil Rogers as new CEO, Lars Wingefors becomes Executive Chairman	06-10	FW
Embracer Appoints Phil Rogers As New CEO	06-10	RE
Embracer appoints Phil Rogers as new CEO	06-10	FW
Lars Wingefors proposed as Executive Chairman of Embracer	06-10	FW
Lancelot Sweden increased by 2.7 percent in May – sold Asker	06-10	FW
Handelsbanken: Embracer's spin-off could be an important trigger – reiterates buy recommendation	05-27	FW
Several target prices lowered for Embracer after report	05-23	FW
DNB Asset Management flags up its stake in Embracer	05-23	FW
Kepler Cheuvreux lowers its target price for Embracer to SEK 118 (121), reiterates buy recommendation	05-23	FW
Deutsche Bank lowers its target price for Embracer to SEK 110 (135), reiterates hold	05-23	FW
Barclays lowers target price for Embracer to SEK 110 (125), reiterates neutral rating - BN	05-23	FW
Nordea lowers target price for Embracer to SEK 130 (165), reiterates buy recommendation	05-23	FW
Embracer's head of human resources Ian Gulam buys shares for SEK 0.35 million	05-23	FW
SEB lowers target price for Embracer to SEK 112 (128), reiterates hold recommendation - BN	05-23	FW
DNB Carnegie lowers target price for Embracer to SEK 140 (150), reiterates buy recommendation - BN	05-23	FW
Pareto Securities lowers its target price for Embracer to SEK 170 (180), reiterates buy recommendation	05-23	FW
European stocks pressured by rising bond yields, weak economic data	05-22	RE
Embracer Group AB, Q4 2025 Earnings Call, May 22, 2025	05-22
Nordnet savers buy when Embracer plummets	05-22	FW
Di: Ignore the share price slump, Embracer is on the right track	05-22	FW
Embracer leans on back catalogue as game delays shake industry profits	05-22	RE
Stockholm Bullets - Cinclus Pharma surges on commercialization agreement	05-22	FW